1. Home
  2. PRPH vs RDHL Comparison

PRPH vs RDHL Comparison

Compare PRPH & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProPhase Labs Inc. (DE)

PRPH

ProPhase Labs Inc. (DE)

HOLD

Current Price

$0.81

Market Cap

4.1M

Sector

Health Care

ML Signal

HOLD

Logo Redhill Biopharma Ltd.

RDHL

Redhill Biopharma Ltd.

HOLD

Current Price

$1.16

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRPH
RDHL
Founded
1989
2009
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1M
3.8M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
PRPH
RDHL
Price
$0.81
$1.16
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.4M
66.4K
Earning Date
11-19-2025
09-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,055,000.00
$9,550,000.00
Revenue This Year
$221.82
$381.91
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
157.62
52 Week Low
$0.80
$1.01
52 Week High
$9.35
$7.00

Technical Indicators

Market Signals
Indicator
PRPH
RDHL
Relative Strength Index (RSI) 78.40 42.15
Support Level $0.08 $1.15
Resistance Level $1.15 $1.24
Average True Range (ATR) 0.05 0.04
MACD 0.08 0.00
Stochastic Oscillator 71.14 18.75

Price Performance

Historical Comparison
PRPH
RDHL

About PRPH ProPhase Labs Inc. (DE)

ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

Share on Social Networks: